Analysts Expect Tenet Healthcare Corp (NYSE:THC) Will Post Earnings of $0.41 Per Share

Equities analysts forecast that Tenet Healthcare Corp (NYSE:THC) will announce earnings per share of $0.41 for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for Tenet Healthcare’s earnings. The highest EPS estimate is $1.33 and the lowest is ($0.17). Tenet Healthcare posted earnings per share of $0.58 in the same quarter last year, which suggests a negative year-over-year growth rate of 29.3%. The company is expected to announce its next earnings results on Monday, November 2nd.

On average, analysts expect that Tenet Healthcare will report full-year earnings of $3.85 per share for the current financial year, with EPS estimates ranging from $1.17 to $5.23. For the next year, analysts expect that the business will report earnings of $2.54 per share, with EPS estimates ranging from $1.70 to $4.29. Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Tenet Healthcare.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings data on Monday, August 3rd. The company reported $1.26 EPS for the quarter, topping analysts’ consensus estimates of ($0.71) by $1.97. The company had revenue of $3.65 billion during the quarter, compared to the consensus estimate of $3.83 billion. Tenet Healthcare had a negative net margin of 0.28% and a positive return on equity of 82.35%. The firm’s revenue for the quarter was down 20.0% compared to the same quarter last year. During the same period last year, the firm earned $0.65 EPS.

A number of equities analysts have recently commented on THC shares. Citigroup reduced their price objective on shares of Tenet Healthcare from $35.00 to $27.00 and set a “buy” rating for the company in a report on Wednesday, May 20th. Truist raised their price objective on shares of Tenet Healthcare from $21.00 to $30.00 in a report on Friday, August 14th. Royal Bank of Canada raised their price objective on shares of Tenet Healthcare from $30.00 to $35.00 in a report on Friday, September 4th. Mizuho reduced their price objective on shares of Tenet Healthcare from $32.00 to $30.00 and set a “buy” rating for the company in a report on Friday, May 29th. Finally, Deutsche Bank increased their target price on shares of Tenet Healthcare from $25.00 to $28.00 and gave the stock a “hold” rating in a research report on Wednesday, August 5th. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $29.00.

NYSE:THC opened at $29.58 on Thursday. The company has a 50-day moving average of $28.19 and a 200-day moving average of $22.03. The company has a market capitalization of $3.12 billion, a price-to-earnings ratio of -58.00, a PEG ratio of 4.43 and a beta of 2.46. Tenet Healthcare has a 52 week low of $10.00 and a 52 week high of $39.37. The company has a debt-to-equity ratio of 24.85, a quick ratio of 1.36 and a current ratio of 1.42.

Institutional investors and hedge funds have recently bought and sold shares of the business. Private Advisor Group LLC acquired a new stake in Tenet Healthcare in the 2nd quarter valued at about $26,000. Rosenberg Matthew Hamilton acquired a new stake in Tenet Healthcare in the 2nd quarter valued at about $36,000. PNC Financial Services Group Inc. increased its position in Tenet Healthcare by 62.2% in the 2nd quarter. PNC Financial Services Group Inc. now owns 2,052 shares of the company’s stock valued at $37,000 after acquiring an additional 787 shares in the last quarter. Stonebridge Capital Advisors LLC acquired a new stake in Tenet Healthcare in the 1st quarter valued at about $46,000. Finally, Advisor Group Holdings Inc. acquired a new stake in Tenet Healthcare in the 1st quarter valued at about $57,000. Hedge funds and other institutional investors own 95.96% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Recommended Story: How Short Selling Works

Get a free copy of the Zacks research report on Tenet Healthcare (THC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.